From Name:
From Email:
To Name:
To Email:

Optional Message:


DPP-4 inhibitors for Type 2 diabetes may cause severe joint pain

from FDA

The U.S. Food and Drug Administration is warning that the Type 2 diabetes medicines sitagliptin, saxagliptin, linagliptin and alogliptin may cause joint pain that can be severe and disabling. The FDA has added a new warning and precaution about this risk to the labels of all medicines in this drug class, called dipeptidyl peptidase-4 inhibitors. See the Drug Safety Communication for a complete list of all FDA-approved DPP-4 inhibitors. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063